Metraipolis › archive › dc_38d8919824de

Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation — Europe PMC PMID:41635486

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41635486
DOI
10.3389/fphar.2026.1685101
License (as archived)
solo-consultazione
Archived
2026-11-06T17:00:16.889Z
SHA-256 of the archived text
6f6444379c91772204394584475bdd604e1fef3e87539e50cb4d482e3e642bff
Stable URL of this page
https://metraipolis.com/documento/dc_38d8919824de

How to cite

Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation — Europe PMC PMID:41635486 — Europe PMC (en), https://europepmc.org/article/MED/41635486 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_38d8919824de (Metraipolis archive dc_38d8919824de, sha256 6f6444379c91772204394584475bdd604e1fef3e87539e50cb4d482e3e642bff)
BibTeX
@misc{dc38d8919824de,
  title = {Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation — Europe PMC PMID:41635486},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41635486},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_38d8919824de; sha256 6f6444379c91772204394584475bdd604e1fef3e87539e50cb4d482e3e642bff},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41635486. Agents can read the archived copy with the MCP tool read_document.